Navigation Links
Pitt study finds 'green' water treatments may not kill bacteria in large building cooling systems
Date:12/10/2010

PITTSBURGH Nonchemical treatment systems are touted as environmentally conscious stand-ins for such chemicals as chlorine when it comes to cleaning the water-based air-conditioning systems found in many large buildings. But a recent study by University of Pittsburgh researchers suggests that this diverse class of water-treatment devices may be ineffective and can allow dangerous bacteria to flourish in the cooling systems of hospitals, commercial offices, and other water-cooled buildings almost as much as they do in untreated water.

The two-year study by a team in Pitt's Swanson School of Engineering is the first to thoroughly investigate the ability of nonchemical treatment devices (NCDs) to control the growth of bacteria in water-based cooling systems. Of the five NCDs tested, none significantly prevented bacterial growth. On the other hand, the researchers found that standard chlorine treatment controlled these organisms, even after bacteria had been allowed to proliferate.

"Our results suggest that equipment operators, building owners, and engineers should monitor systems that rely on NCDs to control microorganisms," said coinvestigator Janet Stout, a research associate in the Swanson School's Department of Civil and Environmental Engineering and director of the Pittsburgh-based Special Pathogens Laboratory. Stout worked with fellow lead investigator Radisav Vidic, chair and William Kepler Whiteford Professor of civil and environmental engineering, and Pitt civil engineering graduate student Scott Duda.

"These cooling systems are energy efficient and, if properly treated, very safe," Stout continued. "But based on our results, nonchemical devices alone may not be enough to control microbial growth. One possible measure is to add chemical treatment as needed to prevent a potential health hazard."

The air systems the team investigated work by piping chilled water throughout a building. The water warms as it exchanges
'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer
2. Scientists begin 5-month study of cloud life cycles
3. Study: mechanism that controls cell movement linked to tumors becoming more aggressive
4. New UCLA study raises questions about genetic testing of newborns
5. Illinois study: Ginseng just got better -- not as bitter
6. Study of how genes activate yields surprising discovery
7. Northern wildfires threaten runaway climate change, study reveals
8. Study reveals new possibility of reversing damage caused by MS
9. Electronic cigarettes are unsafe and pose health risks, UC Riverside study finds
10. Africa can feed itself in a generation: Study
11. New study calls for greater awareness of food supply for children with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pitt study finds 'green' water treatments may not kill bacteria in large building cooling systems
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the fourth ... 2015 after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:7/8/2015)... FRANKLIN LAKES , N.J. and NEW YORK ... and Company) and Guidepoint today announced ... selected start-up healthcare companies with free access to Guidepoint,s ... mentoring several start-ups that are developing cutting-edge technologies to ... of a dedicated Guidepoint research manager, each start-up entrepreneur ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... on the Cohen Y chromosome indicates the Jewish priesthood, the ... a single male lineage dating to ancient Hebrew times. ... Jewish priesthood that traced its patrilineal dynasty and seemed to ... (and brother of Moses), was one of a number of ...
... A scientist at the La Jolla Institute for Allergy & ... (NIH),s top awards -- the 2009 NIH Director,s Pioneer Award. ... costs of up to $4.7 million over five years, and ... whose novel proposals offer the potential to make extraordinary contributions ...
... RICHLAND, Wash. -- An analytical chemist at the Department ... with a National Institutes of Health Director,s New Innovator ... make new research and clinical diagnostic tools that are ... The award, which comes with a $1.5 million, ...
Cached Biology News:New genetic research indicates Jewish priesthood has multiple lineages 2Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award 2Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award 3Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award 4PNNL chemist earns NIH New Innovator Award 2PNNL chemist earns NIH New Innovator Award 3
(Date:7/28/2015)... YORK , July 28, 2015 Tauriga ... a diversified life sciences company, today announced that its ... shares of common stock of the Company from 1,000,000,000 ... on July 27, 2015 at the Law Offices of ...  At the Special Meeting, there were 480,655,929 shares of ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... , July 28, 2015 CSL ... Drug Administration has accepted for review the company,s Biologics ... VIII single-chain (rVIII-SingleChain) for the treatment of hemophilia A. ... endpoints. Hemophilia A is ... factor VIII; nearly all affected patients are male. People ...
(Date:7/28/2015)... Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 ... today announced its financial results for the second ...  sales grew nearly 300% as compared to the ... first launched," said Roger Jeffs, Ph.D., United Therapeutics, ... Orenitram sales was due to an increase in ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11
... , , ... AB (publ),and BioChromix AB announced today the formation of BioChromix Pharma ... its unique,knowledge of molecular chemistry. Karolinska Development will initially take,28 percent ... are very excited about BioChromix Pharma as they have a novel,approach ...
... , ... supports Higher Education and Local Youth by establishing Five College Scholarships. The first ... pursue Bio-Technology studies at NoVA. The company will also sponsor four scholarships for ... ...
... Jan. 13 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... the introduction of new products during a presentation today at the ... the brief presentation, limited by conference organizers to 10 minutes per ... in its cosmetics line during 2010. They include an eye cream ...
Cached Biology Technology:Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 2Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 3RiVIdium Inc. Creates Five Local Scholarships 2Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation 2Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation 3
Glycerokinase; from Bacillus stearothermophilus...
...
...
... safety cabinets Heraeus HERAsafe KS convince with an ... ,The new frameless slanted window does not obscure ... front window design makes it easy to work ... with a height of more than 250 mm ...
Biology Products: